FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
The U.S. Food and Drug Administration approved Rextovy, a 4-milligram over-the-counter naloxone nasal spray, for the emergency treatment of opioid overdose, adding a third nonprescription option that people can buy in pharmacies, convenience stores and online.
Officials said broader availability and market competition could lower costs and put the overdose-reversal medication in more hands as overdose deaths continue their recent decline.